Re: Russell Szmulewitz, Supriya Mohile, Edwin Posadas, et al. A randomized phase 1 study of testosterone replacement for patients with low-risk castration-resistant prostate cancer. Eur Urol 2009;56:97-104.
Friedman
A Edward
AE
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D047072:Aromatase Inhibitors / Q000627:therapeutic use; D017321:Clinical Trials, Phase I as Topic; D004958:Estradiol / Q000378:metabolism; D020249:Hormone Replacement Therapy; D006801:Humans; D008297:Male; D009919:Orchiectomy; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000601:surgery; D016032:Randomized Controlled Trials as Topic; D011944:Receptors, Androgen / Q000187:drug effects; D013739:Testosterone / Q000378:metabolism / Q000627:therapeutic use*; D017211:Treatment Failure
C410798:AR protein, human; D018931:Antineoplastic Agents, Hormonal; D047072:Aromatase Inhibitors; D011944:Receptors, Androgen; D013739:Testosterone; D004958:Estradiol